Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Psychological


Psychosocial screening in a pediatric diabetes clinic: Adolescents’ and mothers’ perspectives

June 27th 2022

Study participants valued psychosocial screening and supported addressing mental health as a routine part of diabetes comprehensive care (Pediatric Diabetes)

Categories: News, Paediatrics, Psychological
Tags: psychosocial

Categories: Paediatrics, Psychological
Tags: psychosocial

Risky self-management behaviors in adolescents with type 1 diabetes: Measurement validation for the Diabetes-Specific Risk-Taking Inventory (DSRI)

June 27th 2022

Overall, initial psychometrics suggest the DSRI is a reliable and valid measure of risks that adolescents may take with their T1D care. This innovative self-report measure has potential to be an actionable clinical tool to screen for high-risk behaviors not routinely assessed in T1D clinical care (Pediatric Diabetes)

Categories: News, Paediatrics, Psychological
Tags: psychometrics, Type 1 Diabetes

Categories: Paediatrics, Psychological
Tags: psychometrics, Type 1 Diabetes

The role of mental disorders in precision medicine for diabetes: a narrative review

June 22nd 2022

Overall, this review demonstrates that addressing mental disorders as a facet of precision medicine could have considerable value for routine diabetes care and has the potential to improve diabetes outcomes (Diabetologia)

Categories: News, Psychological
Tags: mental disorders

Categories: Psychological
Tags: mental disorders

The selective serotonin reuptake inhibitor fluoxetine has direct effects at beta-cells to promote insulin secretion and increase beta-cell mass

June 10th 2022

These data are consistent with a role for fluoxetine in regulating glucose homeostasis through direct effects at beta-cells. Fluoxetine thus demonstrates promise as a preferential antidepressant for patients with concomitant occurrence of depression and diabetes (Diabetes, Obesity and Metabolism)

Categories: Medication, News, Psychological
Tags: beta cells, SSRI

Categories: Medication, Psychological
Tags: beta cells, SSRI

Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients

May 25th 2022

Serum apelin level is reduced in T2DM patients with MCI. Apelin might has protective effect against cognitive impairment and serve as a serum biomarker of T2DM (BMC Endocrine Disorders)

Categories: Monitoring, News, Psychological
Tags: apelin, cognitive impairment, Type 2 Diabetes

Categories: Monitoring, Psychological
Tags: apelin, cognitive impairment, Type 2 Diabetes

Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes

April 6th 2022

Micro-interventions are responsive to real-life circumstances and are adaptive to the specific needs of an individual with diabetes. We conclude that, with current developments in big data analysis, there is a huge potential for precision monitoring in diabetes (Diabetologia)

Categories: Management, Monitoring, News, Psychological
Tags: self-care

Categories: Management, Monitoring, Psychological
Tags: self-care

Achieving diabetes treatment targets in people with registered mental illness is similar or improved compared to those without: analyses of linked observational datasets

March 29th 2022

People with registered mental illness appear comparable or better able to achieve diabetes treatment targets than those without. Achieving HbA1c targets is influenced by social disadvantage (Diabetic Medicine)

Categories: News, Psychological
Tags: glycaemic control

Categories: Psychological
Tags: glycaemic control

Overestimation and underestimation of youths’ health-related quality of life are associated with youth and caregiver positive screens for depression

March 10th 2022

Caregivers often over- or underestimated their children’s QoL. Positive screens for depression among both youths and caregivers contributed to the observed differences between self- and caregiver-reported QoL (Diabetology & Metabolic Syndrome)

Categories: News, Psychological
Tags: QoL

Categories: Psychological
Tags: QoL

Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study

September 9th 2021

Our findings highlight that depression is associated with an increased risk for complications in type 2 diabetes and mortality and should not be neglected (Acta Diabetologica)

Categories: News, Psychological
Tags: depression, Type 2 Diabetes

Categories: Psychological
Tags: depression, Type 2 Diabetes

Activation of Glucagon‐Like Peptide‐1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism‐Independent Pathway

July 13th 2021

We concluded that liraglutide improves cognitive decline in patients with type 2 diabetes mellitus (Journal of the American Academy of Heart Association)

Categories: News, Psychological
Tags: GLP1, Type 2 Diabetes

Categories: Psychological
Tags: GLP1, Type 2 Diabetes

Comprehensive Psychosocial Screening in a Pediatric Diabetes Clinic

February 19th 2021

Comprehensive psychosocial screening can be effectively implemented as part of routine pediatric diabetes care and can identify adolescents in need of additional supports (Pediatric Diabetes)

Categories: News, Paediatrics, Psychological, Screening
Tags: psychosocial

Categories: Paediatrics, Psychological, Screening
Tags: psychosocial

Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study

September 28th 2020

Real-life population-based data suggest a positive effect of metformin on depression rates. This evidence should be used in guiding prescriptions for patients with type 2 diabetes who are at risk for developing depression, including those with prior depression or anxiety and patients with a family history of depression (Diabetes Care)

Categories: News, Psychological
Tags: metformin

Categories: Psychological
Tags: metformin

Diabetes distress and HbA1c in racially/ethnically and socioeconomically diverse youth with type 1 diabetes

August 26th 2020

Diabetes distress is elevated in a younger population of children with T1D who are from racial/ethnic minority backgroundsor have markers of lower SES (Pediatric Diabetes)

Categories: News, Psychological
Tags: HbA1c, Type 1 Diabetes

Categories: Psychological
Tags: HbA1c, Type 1 Diabetes

Sociodemographic disparities in non‐diabetic hyperglycaemia and the transition to type 2 diabetes: evidence from the English Longitudinal Study of Ageing

June 14th 2020

There were socio‐economic differences in NDH prevalence, transition to type 2 diabetes and transition to NDH low‐risk status. Disparities in transitions included the greater likelihood of disadvantaged social groups with NDH developing type 2 diabetes and greater likelihood of advantaged social groups with NDH becoming low‐risk (Diabetic Medicine)

Categories: News, Psychological
Tags: Type 2 Diabetes

Categories: Psychological
Tags: Type 2 Diabetes

Depression in type 1 diabetes and risk of dementia

May 16th 2019

For people with T1D, depression significantly increases dementia risk. Given the pervasiveness of depression in T1D, this has major implications for successful aging in this population recently living to old age (Aging & Mental Health)

Categories: News, Psychological
Tags: depression, Type 1 Diabetes

Categories: Psychological
Tags: depression, Type 1 Diabetes

Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes: A Population-Based Cohort Study

January 15th 2019

Adults with YOD have excess hospitalizations across their lifespan compared with persons with usual-onset T2D, including an unexpectedly large burden of mental illness in young adulthood. Efforts to prevent YOD and intensify cardiometabolic risk factor control while focusing on mental health are urgently needed (Annals of Internal Medicine)

Categories: News, Psychological
Tags: Type 2 Diabetes, YOD

Categories: Psychological
Tags: Type 2 Diabetes, YOD

Excess mortality in Finnish diabetic subjects due to alcohol, accidents and suicide: a nationwide study

October 13th 2018

The findings from this large nationwide cohort indicate higher mortality attributable to suicide, alcohol-related causes and accidents among diabetic patients than among the non-diabetic population. The results emphasize the importance of effective psychosocial interventions among high-risk diabetic patients (EJE)

Categories: News, Psychological
Tags: alcohol, Suicide

Categories: Psychological
Tags: alcohol, Suicide

Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial

October 11th 2018

CSII has substantial psychosocial benefits. PROs demonstrate these benefits (Pediatric Diabetes)

Categories: News, Psychological
Tags: insulin pump, Type 1 Diabetes

Categories: Psychological
Tags: insulin pump, Type 1 Diabetes

Expectations and fear of diabetes-related long-term complications in people with type 2 diabetes at primary care level

August 29th 2018

Prevalence of diabetes-related long-term complications was overestimated in people with diabetes type 2. Approximately one third of the participants showed even great fear. Patient expectation and fear about diabetes-associated complications did not correspondent with data on clinical reality (Acta Diabetologica)

Categories: News, Psychological
Tags: complications, Type 2 Diabetes

Categories: Psychological
Tags: complications, Type 2 Diabetes

Diabetes Fatigue Syndrome

June 4th 2018

The authors share clinical pearls which can help the diabetes healthcare provider diagnose DFS, identify its etiologic factors and manage the syndrome (Diabetes Therapy)

Categories: News, Psychological
Tags: fatigue syndrome

Categories: Psychological
Tags: fatigue syndrome
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

AstraZenecaNapp DiabetesNovo NordiskBoehringer Ingelheim

Silver Sponsors

Abbott Diabetes CareAbout Ascensia Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP-1RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership